AAMI News August 2019, Volume 54, Issue 8
When the most destructive and deadly wildfire in California history raged around Adventist Hospital Feather River last November, the healthcare technology management team reacted instinctively.
Effective Aug. 1, the FDA is operating under a final rule that amends its regulations for supervisory review of “significant decisions” on medical devices
In a move intended to increase transparency in medical device adverse event reporting, the Food and Drug Administration (FDA) has shuttered its Alternative Summary Reporting (ASR)Program.
Human factors experts say they are seeing more early use testing by medical device manufacturers, although they add that newer and smaller companies are lagging in the practice.
- News in Brief
- HTM Professionals Have ‘Valuable’ Role in Early Use Testing
- Researchers Develop ‘Canary in the Coal Mine’ to Detect Bleeding
- Hybrid Course Builds HTM Capacity in Peru
- Disposable Device Designed to Reduce ‘Infusion Confusion’
- In Essay Contest, Students Envision a Tech-Infused Future for Healthcare
- Tech World: 'New Blood' Reenergizes Kentucky Association
- The Big Picture: AAMI President and CEO Accepts Donation
- Retired IAHCSMM Leader Betty Hanna Remembered
- Call for ‘Bright Ideas’
- AAMI Reaches Out to School Counselors to Promote HTM Careers
- One on One with Sam Wright
- AAMI All Star: Deborah Havlik
- Members on the Move
- Standards Spotlight: Kilmer Conference Shines Spotlight on Sterilization and Sterility Assurance
- Advertisers in this Issue